Moreover, a previously unrecognized cancer chemopreventive activity of metformin (i.e. metformin's ability to cause pre-malignant lesions to recede or disappear thus preventing or delaying the onset of invasive cancer) may relate to metformin's ability to unexpectedly upregulate ATM activity in genomically unstable tumor cells [40-42]. The gene discussed is ATM; the disease is cancer.